Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

v3.23.3
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2023
FAIR VALUE MEASUREMENTS  
Schedule of financial assets measured at fair value on a recurring basis

The following fair value hierarchy table presents information about the Company’s financial assets measured at fair value on a recurring basis and indicates the fair value hierarchy of the inputs the Company utilized to determine such fair value (in thousands):

September 30, 2023

Quoted Prices in

Significant

Active Markets

Other

Significant

 

for Identical

Observable

Unobservable

 

Items

Inputs

Inputs

 

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Assets:

Money market funds

$

63,671

$

$

$

63,671

Equity securities

803

803

Other investments

2,000

2,000

Total assets

$

64,474

$

$

2,000

$

66,474

December 31, 2022

Quoted Prices in

Significant 

 Active Markets

Other

Significant

 for Identical

 Observable 

 Unobservable 

 Items

Inputs

Inputs

    

 (Level 1)

    

 (Level 2)

    

 (Level 3)

    

Total

Assets:

 

  

 

  

 

  

 

  

Money market funds

$

51,274

$

$

$

51,274

Commercial paper

39,781

39,781

Corporate bonds

 

 

28,814

 

28,814

U.S. Treasury securities

19,818

19,818

Government bonds

14,744

14,744

Asset-backed securities

3,998

3,998

Equity securities

1,088

1,088

Other investments

2,000

2,000

Total assets

$

52,362

$

107,155

$

2,000

$

161,517

Liabilities:

Contingent consideration

$

$

$

2,587

$

2,587

Total liabilities

$

$

$

2,587

$

2,587

Schedule of Level 3 assets measured at fair value

Nine Months Ended September 30, 

2023

    

2022

Balance at beginning of period

$

2,000

$

6,750

Changes in fair value

(745)

Disposals

(3,155)

Balance at end of period

$

2,000

$

2,850

Schedule of Level 3 liabilities measured at fair value

The following table presents information about the Company’s movement in Level 3 liabilities measured at fair value (in thousands):

Nine Months Ended September 30, 

2023

    

2022

Balance at beginning of period

$

2,587

$

5,654

Payment of contingent consideration liability

(2,390)

(1,500)

Sale of Aerosint

(197)

Changes in fair value

(254)

Balance at end of period

$

$

3,900